Trifocal intraocular lens implantation in eyes with previous corneal refractive surgery for myopia and hyperopia.


Journal

Journal of cataract and refractive surgery
ISSN: 1873-4502
Titre abrégé: J Cataract Refract Surg
Pays: United States
ID NLM: 8604171

Informations de publication

Date de publication:
01 Oct 2021
Historique:
received: 14 10 2020
accepted: 01 03 2021
pubmed: 27 3 2021
medline: 25 2 2023
entrez: 26 3 2021
Statut: ppublish

Résumé

To evaluate the visual and refractive outcomes of trifocal intraocular lens (IOL) implantation in eyes previously treated with myopic and hyperopic corneal refractive laser surgery. Clinica Baviera-AIER-Eye group, Spain. Retrospective comparative case series. The series was divided into 2 groups according to the type of corneal laser refraction (myopic and hyperopic). The main visual and refractive outcome measures included corrected distance visual acuity (CDVA) and uncorrected distance and near visual acuity, safety, efficacy, and predictability. The secondary outcome measures were percentage of enhancement and Nd:YAG capsulotomy and influence of prelaser magnitude of myopia and hyperopia on the outcome of trifocal IOL implantation. The sample comprised 868 eyes (543 patients): myopic, n = 319 eyes (36.7%); and hyperopic, n = 549 eyes (63.2%). Three months postoperatively, visual outcomes were poorer in the hyperopic group than those in the myopic group for mean CDVA (0.06 ± 0.05 vs 0.04 ± 0.04, P < .01) and safety (21% vs 12% of CDVA line loss, P < .05) outcomes. However, precision outcomes were worse in the myopic group than those in the hyperopic group, with a mean spherical equivalent of -0.38 ± 0.3 vs -0.17 ± 0.3 (P < .01). Stratification by magnitude of primary laser treatment revealed poorer visual and safety results in the high hyperopia subgroup (>+3.0 diopters [D]) and poorer precision in the high myopia subgroup (<-5.0 D). Trifocal IOL implantation after photorefractive surgery in eyes previously treated with myopic ablation achieved good visual outcomes but less predictability in the high myopia subgroup. However, eyes with a previous hyperopic corneal ablation achieved excellent precision but worse visual and safety outcomes in the high hyperopia subgroup.

Identifiants

pubmed: 33769921
doi: 10.1097/j.jcrs.0000000000000637
pii: 02158034-202110000-00005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1265-1272

Informations de copyright

Copyright © 2021 Published by Wolters Kluwer on behalf of ASCRS and ESCRS.

Références

Khor WB, Afshari NA. The role of presbyopia-correcting intraocular lenses after laser in situ keratomileusis. Curr Opin Ophthalmol 2013;24:35–40
Cobo-Soriano R, Llovet F, González-López F, Domingo B, Gómez-Sanz F, Baviera J. Factors that influence outcomes of hyperopic laser in situ keratomileusis. J Cataract Refract Surg 2002;28:1530–1538
Alio JL, Abdelghany AA, Abdou AA, Maldonado MJ. Cataract surgery on the previous corneal refractive surgery patient. Surv Ophthalmol 2016;61:769–777
Bottos KM, Leite MT, Aventura-Isidro M, Bernabe-Ko J, Wongpitoonpiya N, Ong-Camara NH, Purcell TL, Schanzlin DJ. Corneal asphericity and spherical aberration after refractive surgery. J Cataract Refract Surg 2011;37:1109–1115
Kohnen T, Mahmoud K, Bühren J. Comparison of corneal higher- order aberrations induced by myopic and hyperopic LASIK. Ophthalmology 2005;112:1692
Alfonso JF, Madrid-Costa D, Poo-López A, Montés-Micó R. Visual quality after diffractive intraocular lens implantation in eyes with previous myopic laser in situ keratomileusis. J Cataract Refract Surg 2008;34:1848–1854
Fernández-Vega L, Madrid-Costa D, Alfonso JF, Montés-Micó R, Poo-López A. Optical and visual performance of diffractive intraocular lens implantation after myopic laser in situ keratomileusis. J Cataract Refract Surg 2009;35:825–832
Muftuoglu O, Dao L, Mootha VV, Verity SM, Bowman RW, Cavanagh HD, McCulley JP. Apodized diffractive intraocular lens implantation after laser in situ keratomileusis with or without subsequent excimer laser enhancement. J Cataract Refract Surg 2010;36:1815–1821
Vrijman V, van der Linden JW, van der Meulen IJE, Mourits MP, Lapid-Gortzak R. Multifocal intraocular lens implantation after previous corneal refractive laser surgery for myopia. J Cataract Refract Surg 2017;43:909–914
Chang JS, Ng JC, Chan VK, Law AK. Visual outcomes, quality of vision, and quality of life of diffractive multifocal intraocular lens implantation after myopic laser in situ keratomileusis: a prospective, observational case series. J Ophthalmol 2017;2017:6459504
Alfonso JF, Fernández-Vega L, Baamonde B, Madrid-Costa D, Montés-Micó R. Refractive lens exchange with spherical diffractive intraocular lens implantation after hyperopic laser in situ keratomileusis. J Cataract Refract Surg 2009;35:1744–1750
Alfonso JF, Fernández-Vega L, Baamonde B, Madrid-Costa D, Montés-Micó R. Visual quality after diffractive intraocular lens implantation in eyes with previous hyperopic laser in situ keratomileusis. J Cataract Refract Surg 2011;37:1090–1096
Vrijman V, van der Linden JW, van der Meulen IJE, Mourits MP, Lapid-Gortzak R. Multifocal intraocular lens implantation after previous hyperopic corneal refractive laser surgery. J Cataract Refract Surg 2018;44:466–470
Li QM, Wang F, Wu ZM, Liu Z, Zhan C, Chen BH, Sima J, Stieger K, Li SW. Trifocal diffractive intraocular lens implantation in patients after previous corneal refractive laser surgery for myopia. BMC Ophthalmol 2020;20:293
Wang W, Ni S, Li X, Chen X, Zhu Y, Xu W. Femtosecond laser-assisted cataract surgery with implantation of a diffractive trifocal intraocular lens after laser in situ keratomileusis: a case report. BMC Ophthalmol 2018;18:160
Chow SSW, Chan TCY, Ng ALK, Kwok AKH. Outcomes of presbyopia-correcting intraocular lenses after laser in situ keratomileusis. Int Ophthalmol 2019;39:1199–1204
Brenner LF, Gjerdrum B, Aakre BM, Lundmark PO, Nistad K. Presbyopic refractive lens exchange with trifocal intraocular lens implantation after corneal laser vision correction: refractive results and biometry analysis. J Cataract Refract Surg 2019;45:1404–1415
Xu ZQ, Cao D, Chen X, Wu S, Wang X, Wu Q. Comparison of clinical performance between trifocal and bifocal intraocular lenses: a meta-analysis. PLoS One 2017;12:e0186522
Bilbao-Calabuig R, Llovet-Rausell A, Ortega-Usobiaga J, Martínez-Del-Pozo M, Mayordomo-Cerdá F, Segura-Albentosa C, Baviera J, Llovet-Osuna F. Visual outcomes following bilateral implantation of two diffractive trifocal intraocular lenses in 10 084 eyes. Am J Ophthalmol 2017;179:55–66
Yoon CH, Shin IS, Kim MK. Trifocal versus bifocal diffractive intraocular lens implantation after cataract surgery or refractive lens exchange: a meta-analysis. J Korean Med Sci 2018;33:e275
R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008. Available at: http://www.R-project.org . Version 2.6.2(2008-02-08)
Wilcox R. Introduction to Robust Estimation and Hypothesis Testing. 3rd ed. Cambridge, MA: Academic Press; 2011
Wang L, Holladay JT, Koch DD. Wang-Koch axial length adjustment for the Holladay 2 formula in long eyes. J Cataract Refract Surg 2018;44:17–22
Ferreira TB, Pinheiro J, Zabala L, Ribeiro FJ. Comparative analysis of clinical outcomes of a monofocal and an extended-range-of-vision intraocular lens in eyes with previous myopic laser in situ keratomileusis. J Cataract Refract Surg 2018;44:149–155
Shah VC, Russo C, Cannon R, Davidson R, Taravella MJ. Incidence of Nd:YAG capsulotomy after implantation of AcrySof multifocal and monofocal intraocular lenses: a case controlled study. J Refract Surg 2010;26:565–568
Bilbao-Calabuig R, Llovet-Osuna F, González-López F, Beltrán J. Nd:YAG capsulotomy rates with two trifocal intraocular lenses. J Refract Surg 2016;32:748–752

Auteurs

Rosario Cobo-Soriano (R)

From the Clinica Baviera-AIER Eye Group, Madrid, Spain (Cobo-Soriano, Ortega-Usobiaga, Rodríguez-Gutiérrez, Tejerina, Llovet, Casco, Baviera); Francisco de Vitoria University, Madrid, Spain (Cobo-Soriano).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH